IL6 and neoplasm: Tumors may contain proinflammatory IL-6 [8–10] that contributes to angiogenesis and cancer cachexia, as well as transforming growth factor beta (TGF-β), a product of regulatory CD4+ T cells (Tregs) which suppress effector immune cell function and contribute to tumor escape from host immune surveillance [11].